0001213900-24-101639.txt : 20241122 0001213900-24-101639.hdr.sgml : 20241122 20241122163912 ACCESSION NUMBER: 0001213900-24-101639 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241122 DATE AS OF CHANGE: 20241122 EFFECTIVENESS DATE: 20241122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NuvOx Therapeutics, Inc. CENTRAL INDEX KEY: 0001966126 ORGANIZATION NAME: IRS NUMBER: 921680380 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-530291 FILM NUMBER: 241490419 BUSINESS ADDRESS: STREET 1: 1635 E. 18TH STREET CITY: TUCSON STATE: AZ ZIP: 85719 BUSINESS PHONE: 520-624-6688 MAIL ADDRESS: STREET 1: 1635 E. 18TH STREET CITY: TUCSON STATE: AZ ZIP: 85719 D 1 primary_doc.xml X0708 D LIVE 0001966126 NuvOx Therapeutics, Inc. 1635 E. 18TH STREET TUCSON AZ ARIZONA 85719 (520) 624-6688 DELAWARE None None Corporation true 2022 Evan Unger 1635 E. 18th Street Tucson AZ ARIZONA 85719 Executive Officer Director Rong Wang 1635 E. 18th Street Tucson AZ ARIZONA 85719 Executive Officer Jennifer Johnson 1635 E. 18th Street Tucson AZ ARIZONA 85719 Executive Officer Jon Saxe 1635 E. 18th Street Tucson AZ ARIZONA 85719 Director Marvin J. Slepian 1635 E. 18th Street Tucson AZ ARIZONA 85719 Director Jonathan T. Schilling 1635 E. 18th Street Tucson AZ ARIZONA 85719 Director Richard Carmona 1635 E. 18th Street Tucson AZ ARIZONA 85719 Director Pharmaceuticals Decline to Disclose 06b false 2024-09-10 false true true false 35000 Donald Capital, LLC 000297763 None None 420 Lexington Avenue, Suite 1402 New York NY NEW YORK 10170 AZ ARIZONA CA CALIFORNIA false 7000000 235000 6765000 false 4 405900 true 0 Donald Capital is entitled to a cash fee equal to six percent (6%) of the gross proceeds for investors they introduce to the Issuer.". 0 false NuvOx Therapeutics, Inc. /s/ Rong Wang Rong Wang Chief Executive Officer 2024-11-22